Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk
Academic Emergency Medicine · 2025
DOI: 10.1111/acem.15045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Emergency Medicine, 2025. Verfasst von David R Vinson und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Permanente Medical Group, Pleasanton, California, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism, Delayed Diagnosis, Informed Consent, Prenatal Diagnosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Kaiser Permanente Northern California Community Health Program, The Permanente Medical Group Delivery Science and Applied Research Program.
Abstract (Originalsprache)
Background
Nonconsent to pulmonary vascular (or advanced) imaging for suspected pulmonary embolism (PE) in pregnancy can delay diagnosis and treatment, increasing risk of adverse outcomes. We sought to understand factors associated with consent and understand outcomes after nonconsent.
Methods
This retrospective cohort study was undertaken across 21 community hospitals from October 1, 2021, through March 31, 2023. We included gravid patients undergoing diagnostics for suspected PE who were recommended advanced imaging. The primary outcome was verbal consent to advanced imaging. Diagnostic settings were nonobstetric (99% emergency departments [EDs]) and obstetrics (labor and delivery and outpatient clinics). Using quasi‐Poisson regression, we calculated adjusted relative risks (aRRs) of consenting with 95% confidence intervals (CIs). We also reported symptom resolution and delayed imaging at follow‐up and 90‐day PE outcomes.
Results
Imaging was recommended for 405 outpatients: median age was 30.5 years; 50% were in the third trimester. Evaluation was more common in nonobstetric (83%) than obstetric settings (17%). Overall, 314 (78%) agreed to imaging and 91 (22%) declined imaging. Consenting was more prevalent in obstetric settings compared with nonobstetric settings: 99% versus 73% ( p < 0.001). When adjusted for demographic and clinical variables, including pretest probability, only obstetric setting was independently associated with consenting: aRR 1.26 (95% CI 1.09–1.44). Seventy‐nine (87%) patients declining imaging had 30‐day follow‐up. Eight of 12 who reported persistent or worsening symptoms on follow‐up were again recommended advanced imaging and consented. Imaging was negative. None who initially declined imaging were diagnosed with PE or died within 90 days.
Conclusions
One in five gravid patients suspected of PE declined advanced imaging, more commonly in nonobstetric (principally ED) settings than obstetric settings. Patients symptomatic on follow‐up responded favorably to subsequent imaging recommendations without 90‐day outcomes. Improving the communication and documentation of informed consent and securing close follow‐up for nonconsenters may mitigate risks of missed and delayed PE diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Permanente Medical Group, Pleasanton, California, USA.
- Kaiser Permanente Northern California Division of Research, Pleasanton, California, USA.
- Department of Emergency Medicine, Kaiser Permanente Roseville Medical Center, Roseville, California, USA.
- California Northstate University College of Medicine, Elk Grove, California, USA.
- Department of Biology, New York University, New York, New York, USA.
- Department of Neurobiology, Physiology and Behavior, University of California, Davis, California, USA.
ORCID-Profile: David R Vinson
Förderung
- Kaiser Permanente Northern California Community Health Program
- The Permanente Medical Group Delivery Science and Applied Research Program
Zitieren
APA
Vinson, D. R., Somers, M. J., Qiao, E., Campbell, A. R., Heringer, G. V., Florio, C. J., Zekar, L., Middleton, C. E., Woldemariam, S. T., Gupta, N., Poth, L. S., Reed, M. E., Roubinian, N. H., Raja, A. S., & Sperling, J. D. (2025). Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk. Academic Emergency Medicine. https://doi.org/10.1111/acem.15045
Vancouver
Vinson DR, Somers MJ, Qiao E, Campbell AR, Heringer GV, Florio CJ, et al. Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk. Academic Emergency Medicine. 2025. doi:10.1111/acem.15045
BibTeX
@article{Vinson2025,
author = {Vinson, David R and Somers, Madeline J and Qiao, Edward and Campbell, Aidan R and Heringer, Grace V and Florio, Cole J and Zekar, Lara and Middleton, Cydney E and Woldemariam, Sara T and Gupta, Nachiketa and Poth, Luke S and Reed, Mary E and Roubinian, Nareg H and Raja, Ali S and Sperling, Jeffrey D},
title = {Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk},
journal = {Academic Emergency Medicine},
year = {2025},
doi = {10.1111/acem.15045}
}
EUVIMED